PSYCHLES
@psychles.bsky.social
33 followers
55 following
4 posts
Researching legal, ethical, and social aspects of Psychedelics at the University of Birmingham. Current project: 'Psychedelics & Regulatory Decision-making'.
Posts
Media
Videos
Starter Packs
Pinned
PSYCHLES
@psychles.bsky.social
· May 29
Reposted by PSYCHLES
Reposted by PSYCHLES
josh hardman
@josh-hardman.bsky.social
· Aug 28
Pα+ Psychedelic Bulletin #207: Lykos Rebrands to Resilient; Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision; AbbVie-Gilgamesh Deal Viewed as Validation - Psychedelic Alpha
Lykos Therapeutics Rebrands to Resilient Pharmaceuticals • Pharma Pushes Back on Norway’s Off-Label Ketamine Decision • AbbVie–Gilgamesh Deal Viewed as Validation for Short-Acting Psychedelics •
psychedelicalpha.com
Reposted by PSYCHLES
Reposted by PSYCHLES
Reposted by PSYCHLES
Reposted by PSYCHLES
Michael Pollan
@michaelpollan.bsky.social
· Jun 13
Texas passes nation’s first ibogaine research funding bill; Colorado’s first Natural Medicine client; and Psilocybin’s effects wane a year after dosing
Plus: Oregon Psilocybin services releases its first quarterly demographic data report and Could the Czech Republic be the first EU country to approve psilocybin-assisted therapy?
themicrodose.substack.com
Reposted by PSYCHLES
DrugWise
@drugwise.bsky.social
· Jun 5
PSYCHLES
@psychles.bsky.social
· May 29
Reposted by PSYCHLES
josh hardman
@josh-hardman.bsky.social
· May 24
Matt Zorn, the Government’s Former Adversary, Is Now Its Psychedelics Czar - Psychedelic Alpha
Matt Zorn made his name suing federal agencies over cannabis and psychedelics policy. Now, he’s inside the system as Deputy General Counsel at HHS, with what appears to be a mandate over psychedelics…
psychedelicalpha.com
Reposted by PSYCHLES
josh hardman
@josh-hardman.bsky.social
· May 27
Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive Disorder Study - Psychedelic Alpha
As Gilgamesh Pharmaceuticals is set to share positive results from its Phase 2a study of GM-2505 (aka bretisilocin, a serotonergic psychedelic) in major depressive disorder later today at ASCP…
psychedelicalpha.com
Reposted by PSYCHLES
PSYCHLES
@psychles.bsky.social
· May 13
Reposted by PSYCHLES
josh hardman
@josh-hardman.bsky.social
· May 12
Dispatch from Breaking Convention 2025: Key Takeaways from Europe’s Largest Psychedelic Summit (Part 2) - Psychedelic Alpha
From 17–19 April, the UK’s seventh biennial psychedelic conference tackled some of the field’s most urgent questions. In this second instalment, we explore the ethical dilemmas of giving psychedelics…
psychedelicalpha.com
Reposted by PSYCHLES